These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26149404)

  • 1. Treatment with escitalopram improves the attentional bias toward negative facial expressions in patients with major depressive disorders.
    Zhou Z; Cao S; Li H; Li Y
    J Clin Neurosci; 2015 Oct; 22(10):1609-13. PubMed ID: 26149404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J; Goa KL
    CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attentional biases in patients suffering from unipolar depression: results of a dot probe task investigation.
    Trapp W; Kalzendorf C; Baum C; Hajak G; Lautenbacher S
    Psychiatry Res; 2018 Mar; 261():325-331. PubMed ID: 29331850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escitalopram in the treatment of major depressive disorder: a meta-analysis.
    Kennedy SH; Andersen HF; Thase ME
    Curr Med Res Opin; 2009 Jan; 25(1):161-75. PubMed ID: 19210149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
    Azorin JM; Llorca PM; Despiegel N; Verpillat P
    Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anhedonia among patients with Major Depressive Disorder: A comparison between patients on escitalopram and healthy controls.
    Ng CG; Wong SK; Loh HS; Yee A
    Clin Ter; 2014; 165(6):e384-90. PubMed ID: 25524191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genome-wide association study of escitalopram treatment outcomes in patients with major depressive disorder.
    Ren S; Peng H; Zhang J; Yang J; He Y; Sun Z; Wang G
    Gene; 2024 Oct; 926():148596. PubMed ID: 38782219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
    Clayton AH; Croft HA; Horrigan JP; Wightman DS; Krishen A; Richard NE; Modell JG
    J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder.
    Jarčušková D; Tkáč I; Hlaváčová N; Yaluri AS; Kozárová M; Habalová V; Klimčáková L; Židzik J; Javorský M; Bednářová A
    BMC Psychiatry; 2024 Oct; 24(1):690. PubMed ID: 39407134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal functional and structural neuroimaging investigation of major depressive disorder following treatment with duloxetine.
    Fu CH; Costafreda SG; Sankar A; Adams TM; Rasenick MM; Liu P; Donati R; Maglanoc LA; Horton P; Marangell LB
    BMC Psychiatry; 2015 Apr; 15():82. PubMed ID: 25880400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of alcohol dependence in patients with co-morbid major depressive disorder--predictors for the outcomes with memantine and escitalopram medication.
    Muhonen LH; Lahti J; Sinclair D; Lönnqvist J; Alho H
    Subst Abuse Treat Prev Policy; 2008 Oct; 3():20. PubMed ID: 18834506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, randomized, double-blind, flexible-dose study.
    Ou JJ; Xun GL; Wu RR; Li LH; Fang MS; Zhang HG; Xie SP; Shi JG; Du B; Yuan XQ; Zhao JP
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):639-46. PubMed ID: 20340011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attentional bias modification reduces clinical depression and enhances attention toward happiness.
    Dai Q; Hu L; Feng Z
    J Psychiatr Res; 2019 Feb; 109():145-155. PubMed ID: 30551021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder.
    Leuchter AF; Lesser IM; Trivedi MH; Rush AJ; Morris DW; Warden D; Fava M; Wisniewski SR; Luther JF; Perales M; Gaynes BN; Stewart JW
    J Psychiatr Pract; 2008 Sep; 14(5):271-80. PubMed ID: 18832958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual function improves as depressive symptoms decrease during treatment with escitalopram: results of a naturalistic study of patients with major depressive disorder.
    Weber S; Frokjaer VG; Armand S; Nielsen JH; Knudsen GM; Joergensen MB; Stenbaek DS; Giraldi A
    J Sex Med; 2023 Feb; 20(2):161-169. PubMed ID: 36763929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escitalopram but not placebo modulates brain rhythmic oscillatory activity in the first week of treatment of Major Depressive Disorder.
    Leuchter AF; Hunter AM; Jain FA; Tartter M; Crump C; Cook IA
    J Psychiatr Res; 2017 Jan; 84():174-183. PubMed ID: 27770740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH; Andersen HF; Lam RW
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized, Double-Blind, Placebo-Controlled Trial of Escitalopram in Patients with Asthma and Major Depressive Disorder.
    Brown ES; Sayed N; Van Enkevort E; Kulikova A; Nakamura A; Khan DA; Ivleva EI; Sunderajan P; Bender BG; Holmes T
    J Allergy Clin Immunol Pract; 2018; 6(5):1604-1612. PubMed ID: 29409976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does negative affectivity predict differential response to an SSRI versus a non-SSRI antidepressant?
    Gerra ML; Marchesi C; Amat JA; Blier P; Hellerstein DJ; Stewart JW
    J Clin Psychiatry; 2014 Sep; 75(9):e939-44. PubMed ID: 25295437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.
    Wade AG; Fernández JL; François C; Hansen K; Danchenko N; Despiegel N
    Pharmacoeconomics; 2008; 26(11):969-81. PubMed ID: 18850765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.